ACIP releases 2024 recommended immunization schedule for children and adolescents

The Advisory Committee on Immunization Practices (ACIP) has published its 2024 recommended immunization schedule. This guideline document is intended for children and adolescents aged 18 years or younger in the United States. It is not a clinical trial or observational study and therefore does not report efficacy, safety, or outcomes data from research.

No specific intervention, comparator, or outcomes are reported, as this is a practice recommendation. The document describes the recommended timing and types of vaccines for this population. No numerical results, effect sizes, or statistical measures are provided.

Safety and tolerability data are not reported within this guideline document. The publication does not list specific limitations, as it is a consensus recommendation rather than a research study. The practice relevance is that this is the recommended immunization schedule for clinical practice in 2024. Clinicians should refer to the full schedule for detailed age-based recommendations and any footnotes regarding special populations or catch-up schedules.